Novo Nordisk A/S
SWB:NOV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Novo Nordisk A/S
SWB:NOV
|
DK |
|
I
|
Interface Inc
F:IF6N
|
US |
|
M
|
Meta Platforms Inc
MIL:MVRS
|
US |
|
Y
|
Yara International ASA
SWB:IU2
|
NO |
|
A
|
Almonty Industries Inc
XETRA:ALI
|
CA |
|
Exlservice Holdings Inc
NASDAQ:EXLS
|
US |
|
P
|
Puma SE
XBER:PUM
|
DE |
|
Dios Fastigheter AB
STO:DIOS
|
SE |
|
Steven Madden Ltd
F:SJM
|
US |
|
T
|
Tesla Inc
MIL:TSLA
|
US |
|
Markel Corp
NYSE:MKL
|
US |
|
Celyad Oncology SA
XBRU:CYAD
|
BE |
|
A
|
ANSYS Inc
F:AKX
|
US |
|
V
|
Vianet Group PLC
XBER:AS2
|
UK |
|
L
|
LivePerson Inc
DUS:LVO
|
US |
|
G
|
General Motors Co
BMV:GM
|
US |
|
O
|
Owens Corning
F:O5Q
|
US |
|
M
|
Mandarin Oriental International Ltd
LSE:MDOB
|
HK |
|
V
|
ViacomCBS Inc
F:0VV
|
US |
|
C
|
Canfor Corp
OTC:CFPZF
|
CA |
Wall St Price Targets
NOV Price Targets Summary
Novo Nordisk A/S
According to Wall Street analysts, the average 1-year price target for NOV is 44.838 EUR with a low forecast of 27.16 EUR and a high forecast of 64.095 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NOV's stock price target?
Price Target
44.838
EUR
According to Wall Street analysts, the average 1-year price target for NOV is 44.838 EUR with a low forecast of 27.16 EUR and a high forecast of 64.095 EUR.
What is the Revenue forecast for Novo Nordisk A/S?
Projected CAGR
1%
Over the last 14 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 1%.
What is the Gross Profit forecast for Novo Nordisk A/S?
Projected CAGR
2%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 3 years is 2%.
What is the Operating Income forecast for Novo Nordisk A/S?
Projected CAGR
2%
Over the last 14 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 2%.
What is the Pre-Tax Income forecast for Novo Nordisk A/S?
Projected CAGR
0%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 14%. The projected CAGR for the next 3 years is 0%.
What is the Net Income forecast for Novo Nordisk A/S?
Projected CAGR
-1%
Over the last 14 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 3 years is -1%.
